Search
Dr Timothy Michael Robinson

Dr Timothy Michael Robinson

Tim

Medical oncology 06162507

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Specialises in

  • Breast

Offers

  • Face-to-face consultations
  • Video and telephone consultations

About me

I am a Consultant Senior Lecturer in Medical Oncology at the University of Bristol and an Honorary Consultant Medical Oncologist at University Hospitals Bristol and Weston NHS Foundation Trust specialising in breast cancer. I practice in all areas of breast oncology but have a special interest in younger women with breast cancer, management of the side effects of treatment, antibody drug conjugates, including Her2 low disease, molecular testing and in triple negative breast cancer. I am passionate about improving patient care and helping patients decide the best individual treatment for them and I always spend time trying to go above and beyond for patients with appointments never shorter than 30 minutes for follow ups or 60 minutes for new patients or second opinions. I regularly give talks for Breast Cancer Now for women with breast cancer to help them understand treatment options for both metastatic breast cancer and TNBC.

I completed my medical oncology clinical and academic training in Bristol and undertook a Cancer Research UK Clinical Fellowship leading to being awarded a PhD from Cardiff University examining the role of breast cancer stem cells in chemo-resistance and exploring novel therapeutic strategies. I also undertook a postgraduate diploma in oncology from the Institute of Cancer Research University of London. I was the recipient of a Coltmans Scholar Award from the San Antonio Breast Cancer Symposium, the worlds largest breast cancer meeting, for work on the gut microbiome and breast cancer, and have multiple peer-reviewed publications. I have presented widely at national and international conferences.

I am heavily involved in clinical trials as a principal investigator in Bristol and chief investigator. This includes global chief investigator roles in 2 clinical studies for metastatic breast cancer. I am a member of national collaborative research groups and was appointed to the National Cancer Institute Breast Cancer Precision Medicine Working group in 2022 and I am member of the NICE expert panel of breast oncologists for the breast cancer guideline committee.

I strive to provide personalised care using up-to-date pragmatic evidenced-based medicine.

Areas of interest

Breast cancer; chemotherapy; immunotherapy; targeted therapy; endocrine therapy; hormone therapy; her2 low; antibody drug conjugates; younger women with breast cancer; survivorship; menopausal symptoms

Medical secretaries

My qualifications & training
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

    GenesisCare, Bristol (5-50)

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (1-5)

    GenesisCare, Bristol (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.